Supplement
Melatonin is a hormone your brain releases in the evening that tells your body it is time to sleep and helps set your internal clock. Most people look at it for sleep and insomnia, and the evidence is strong: in five studies, insomnia symptoms improved, including in older adults and in children who struggled to fall asleep. Those studies were fairly small, though, with 259 people in total, so the findings say more about who was studied than about everyone.
Sources: PMID 19584739; PMID 21340475
- Updated
- How we grade
- 38 studies cited
- Best evidence
- Grade A
- Conditions studied
- 30
- Outcomes
- 141
- Graded outcomes
- 23148
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Insomnia Signs and Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 5 studies | 259 people | ||
Studies that measured insomnia signs and symptoms
| ||||||
| Sleep Quality | Improves (the measure goes up) | 211 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Abdominal Pain Moderate Improvement | Improves (the measure goes down) | Moderate effect | 115 people | |||
| Irritable Bowel Syndrome Symptoms | Improves (the measure goes down) | 1 study | 115 people | |||
Studies that measured irritable bowel syndrome symptoms | ||||||
| Quality of Life | Improves (the measure goes up) | 115 people | ||||
Body Composition
- Blood Pressure: improves
- Body Mass Index (BMI): improves
- Hip Circumference: improves
Tinnitus
- Sleep Quality: improves
- Tinnitus Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Sleep Quality Small Improvement | Improves (the measure goes up) | Small effect | 85 people | |||
| Tinnitus Symptoms | Improves (the measure goes down) | 4 studies | 217 people | |||
Studies that measured tinnitus symptoms | ||||||
Depression
- Depression Symptoms: improves
- Serum BDNF: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 2,070 people | |||
| Serum BDNF | Improves (the measure goes up) | 1 study | 2,070 people | |||
Migraine Headache
- Insomnia Signs and Symptoms: improves
- Migraine Frequency: improves
- Migraine Duration: improves
Sleep Health
- Insomnia Signs and Symptoms: improves
- Migraine Frequency: improves
- Sleep Latency: improves
Cognitive Improvement
- Insomnia Signs and Symptoms: improves
- Sleep Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Insomnia Signs and Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 5 studies | 40 people | ||
Studies that measured insomnia signs and symptoms
| ||||||
| Sleep Quality | Improves (the measure goes up) | 40 people | ||||
Obstructive Sleep Apnea (OSA)
- Insomnia Signs and Symptoms: improves
- Sleep Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Insomnia Signs and Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 5 studies | 1 person | ||
Studies that measured insomnia signs and symptoms
| ||||||
| Sleep Quality | Improves (the measure goes up) | 1 person | ||||
High Blood Pressure
- Anti-Oxidant Enzyme Profile: improves
- Adrenaline
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 1 study | 30 people | ||
Studies that measured anti-oxidant enzyme profile | ||||||
| Adrenaline No effect | NoneNo effect | 17 people | ||||
| Blood Pressure | Improves (the measure goes down) | 5 studies | 52 people | |||
Studies that measured blood pressure
| ||||||
| Cerebral Blood Flow | Improves (the measure goes up) | 1 study | 10 people | |||
Studies that measured cerebral blood flow | ||||||
| Blood glucose | Improves (the measure goes down) | 30 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 30 people | ||||
| Fibrinogen | Improves (the measure goes up) | 30 people | ||||
| Heart Rate | Improves (the measure goes down) | 17 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 30 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 30 people | ||||
| Noradrenaline | Improves (the measure goes up) | 17 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 30 people | ||||
| Total cholesterol | Improves (the measure goes down) | 30 people | ||||
| Triglycerides | Improves (the measure goes down) | 30 people | ||||
High Cholesterol
- Anti-Oxidant Enzyme Profile: improves
- Blood Pressure: improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 1 study | 30 people | ||
Studies that measured anti-oxidant enzyme profile | ||||||
| Blood Pressure | Improves (the measure goes down) | 5 studies | 30 people | |||
Studies that measured blood pressure
| ||||||
| Blood glucose | Improves (the measure goes down) | 30 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 30 people | ||||
| Fibrinogen | Improves (the measure goes up) | 30 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 30 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 30 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 30 people | ||||
| Total cholesterol | Improves (the measure goes down) | 30 people | ||||
| Triglycerides | Improves (the measure goes down) | 30 people | ||||
Metabolic Syndrome
- Anti-Oxidant Enzyme Profile: improves
- Blood Pressure: improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 1 study | 30 people | ||
Studies that measured anti-oxidant enzyme profile | ||||||
| Blood Pressure | Improves (the measure goes down) | 5 studies | 30 people | |||
Studies that measured blood pressure
| ||||||
| Blood glucose | Improves (the measure goes down) | 30 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 30 people | ||||
| Fibrinogen | Improves (the measure goes up) | 30 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 30 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 30 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 30 people | ||||
| Total cholesterol | Improves (the measure goes down) | 30 people | ||||
| Triglycerides | Improves (the measure goes down) | 30 people | ||||
Soccer Performance
- Anti-Oxidant Enzyme Profile: improves
- Exercise-Induced Oxidation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 1 study | 16 people | ||
| Exercise-Induced Oxidation | Changes; see studies | 2 studies | 16 people |
Endometriosis
- Dyschezia: improves
- Dysmenorrhea Symptoms: improves
- Serum BDNF: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Dyschezia Moderate Improvement | Improves (the measure goes up) | Moderate effect | 40 people | |||
| Dysmenorrhea Symptoms | Improves (the measure goes down) | 1 study | 40 people | |||
| Serum BDNF | Improves (the measure goes up) | 1 study | 40 people | |||
| Dyspareunia | Improves (the measure goes up) | 40 people | ||||
| Dysuria | Improves (the measure goes up) | 40 people | ||||
| Endometriosis-associated pelvic pain | Improves (the measure goes down) | 40 people | ||||
| Sleep Quality | Improves (the measure goes up) | 40 people |
Gastroesophageal Reflux Disease (GERD)
- Gastrin: changes; see studies
- Lower Esophageal Pressure: improves
- GERD Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Gastrin Moderate Increase | Changes; see studies | Moderate effect | 60 people | |||
| Lower Esophageal Pressure | Improves (the measure goes up) | 1 study | 60 people | |||
| GERD Symptoms | Improves (the measure goes down) | 60 people | ||||
| Heartburn Symptoms | Improves (the measure goes down) | 60 people |
General Gut Health
- Gastrin: changes; see studies
- Plasma Melatonin: improves
- Stomach Ulcers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Gastrin Moderate Increase | Changes; see studies | Moderate effect | 30 people | |||
| Plasma Melatonin | Improves (the measure goes up) | 1 study | 30 people | |||
| Stomach Ulcers | Improves (the measure goes up) | 30 people |
H. Pylori Infection
- Gastrin: changes; see studies
- Ghrelin: improves
- Leptin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Gastrin Moderate Increase | Changes; see studies | Moderate effect | 21 people | |||
| Ghrelin | Improves (the measure goes up) | 1 study | 21 people | |||
| Leptin | Improves (the measure goes up) | 1 study | 21 people | |||
| Stomach Ulcers | Improves (the measure goes up) | 21 people |
Nonalcoholic Steatohepatitis (NASH)
- Adiponectin: improves
- Ghrelin: improves
- Leptin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin Small Increase | Improves (the measure goes up) | Small effect | 16 people | |||
| Ghrelin | Improves (the measure goes up) | 1 study | 16 people | |||
| Leptin | Improves (the measure goes up) | 1 study | 16 people | |||
| Glycemic Control | Improves (the measure goes up) | 16 people | ||||
| Insulin | Changes; see studies | 16 people | ||||
| Liver Enzymes | Changes; see studies | 16 people | ||||
| Resistin | Improves (the measure goes up) | 16 people |
H. Pylori Infection
- Gastrin: improves
- Ghrelin: improves
- Leptin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Gastrin Moderate Increase | Improves (the measure goes up) | Moderate effect | 21 people | |||
| Ghrelin | Improves (the measure goes up) | 1 study | 21 people | |||
| Leptin | Improves (the measure goes up) | 1 study | 21 people | |||
| Stomach Ulcers | Improves (the measure goes up) | 21 people |
Multiple Sclerosis (MS)
- Heart Rate Variability
- Walking Ability: improves
- Sleep Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Heart Rate Variability No effect | NoneNo effect | 1 study | 27 people | |||
| Walking Ability | Improves (the measure goes up) | 1 study | 27 people | |||
| Sleep Quality | Improves (the measure goes up) | 27 people |
Breast Cancer
- Breast Cancer Risk
- IGF-1: improves
- Estrogen: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Breast Cancer Risk No effect | NoneNo effect | 1 study | 863 people | |||
| IGF-1 | Improves (the measure goes up) | 1 study | 86 people | |||
| Estrogen | Changes; see studies | 86 people |
Metabolic Health
- Adrenaline
- Blood Pressure: improves
- Exercise-Induced Oxidation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline No effect | NoneNo effect | 14 people | ||||
| Blood Pressure | Improves (the measure goes down) | 5 studies | 14 people | |||
| Exercise-Induced Oxidation | Changes; see studies | 2 studies | 20 people | |||
| Growth Hormone | Improves (the measure goes up) | 2 studies | 18 people | |||
| Blood Flow | Improves (the measure goes up) | 14 people | ||||
| Cortisol | Improves (the measure goes down) | 10 people | ||||
| Heart Rate | Improves (the measure goes down) | 14 people | ||||
| Inflammation | Improves (the measure goes down) | 20 people | ||||
| Muscle Damage | Changes; see studies | 20 people | ||||
| Noradrenaline | Improves (the measure goes up) | 14 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 20 people | ||||
| Prolactin | Improves (the measure goes up) | 10 people |
General Cardiovascular Health
- Adrenaline
- Blood Pressure: improves
- Blood Flow: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline No effect | NoneNo effect | 40 people | ||||
| Blood Pressure | Improves (the measure goes down) | 5 studies | 1,543 people | |||
| Blood Flow | Improves (the measure goes up) | 14 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 1,543 people | ||||
| Dopamine | Improves (the measure goes up) | 26 people | ||||
| Heart Rate | Improves (the measure goes down) | 14 people | ||||
| Hip Circumference | Improves (the measure goes down) | 1,543 people | ||||
| Noradrenaline | Improves (the measure goes up) | 40 people | ||||
| Waist circumference | Improves (the measure goes down) | 1,543 people | ||||
| Weight | Improves (the measure goes down) | 1,543 people |
Type 2 Diabetes
- Blood glucose
- HbA1c: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 291 people | ||||
| HbA1c | Improves (the measure goes down) | 1 study | 325 people |
Memory Improvement
- Adrenaline
- Anxiety Symptoms: improves
- Alertness: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline No effect | NoneNo effect | 50 people | ||||
| Anxiety Symptoms | Improves (the measure goes down) | 1 study | 50 people | |||
| Alertness | Improves (the measure goes up) | 50 people | ||||
| Attention | Improves (the measure goes up) | 50 people | ||||
| Cortisol | Improves (the measure goes down) | 50 people | ||||
| Memory | Improves (the measure goes up) | 50 people | ||||
| Noradrenaline | Improves (the measure goes up) | 50 people |
Stress
- Adrenaline
- Anxiety Symptoms: improves
- Alertness: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline No effect | NoneNo effect | 50 people | ||||
| Anxiety Symptoms | Improves (the measure goes down) | 1 study | 50 people | |||
| Alertness | Improves (the measure goes up) | 50 people | ||||
| Attention | Improves (the measure goes up) | 50 people | ||||
| Cortisol | Improves (the measure goes down) | 50 people | ||||
| Memory | Improves (the measure goes up) | 50 people | ||||
| Noradrenaline | Improves (the measure goes up) | 50 people |
Chronic Kidney Disease (CKD)
- Cerebral Blood Flow: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cerebral Blood Flow | Improves (the measure goes up) | 1 study | 10 people |
General Cancer Care and Prevention
- Cancer Mortality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cancer Mortality | Improves (the measure goes down) | 1 study | 643 people |
Eye Health
- Intraocular Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Intraocular Pressure | Improves (the measure goes up) | 1 study | 9 people |
Jet Lag
- Jet Lag Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Jet Lag Symptoms | Improves (the measure goes down) | 1 study | 142 people |
What the published studies found
5 automated readings
LDL cholesterol
The studies disagree. The best available review (2026, 10 studies) found little or no difference in LDL cholesterol, while 3 of the 8 studies read found an improvement. The evidence is very weak.
8 studies counted of 9 read: 4 reviews and 2 trials (79 people in the trials).
- Systematic review, 2026; 10 studies; patients with chronic kidney disease: no clear difference (the review the verdict rests on).
Also, MLT supplementation had no significant effect on triglycerides, total cholesterol, low-density lipoprotein cholesterol, or …
The effect of melatonin supplementation on lipid profile, oxidative stress, inflammatory marker, and sleep quality in patients with chronic kidney disease: a GRADE assessed meta-analysis - Meta-analysis, 2025; 63 studies: improves. Comprehensive Effects of Melatonin Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis
- Meta-analysis, 2019; 12 studies, 641 people: no clear difference.
melatonin may improve low density lipoprotein cholesterol
The effect of melatonin supplementation on lipid profile and anthropometric indices: A systematic review and meta-analysis of clinical trials - Meta-analysis, 2018; 8 studies: no clear difference. Effects of melatonin supplementation on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials
- Non-randomised trial, 2025; 154 people; type 2 diabetes patients with cognitive impairment: no clear difference.
No significant effects were observed on LDL-c
Melatonin Supplementation Improves Cognitive Function in Type-2 Diabetes Mellitus: A Quasi-Experimental Study - Randomised trial, 2019; 58 people; women with polycystic ovary syndrome: improves. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- Non-randomised trial, 2011; 30 people; patients with metabolic syndrome: improves. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome
- Crossover trial, 1997; 21 people; patients with hypercholesterolemia: no clear difference.
no statistically significant difference in lipid components
Effect of melatonin on serum lipids in patients with hypercholesterolemia: a pilot study
- Systematic review, 2026; 10 studies; patients with chronic kidney disease: no clear difference (the review the verdict rests on).
Jet lag
The studies disagree. A Cochrane review (2002, 10 studies) found an improvement in jet lag, while 1 of the 10 studies read found no clear difference. The evidence is very weak.
10 studies counted of 10 read: 7 reviews and 3 trials (77 people in the trials).
- Systematic review, 2002; 10 studies; airline passengers, staff, or military personnel crossing time zones: improves (the review the verdict rests on).
decreased jet-lag from flights crossing five or more time zones
Melatonin for the prevention and treatment of jet lag - Meta-analysis, 2021; 23 studies; healthy adults: improves.
melatonin reduced self-reported jetlag following eastbound
Efficacy of Functional Foods, Beverages, and Supplements Claiming to Alleviate Air Travel Symptoms: Systematic Review and Meta-Analysis - Meta-analysis, 2015; 11 studies; travelers crossing multiple time zones: improves.
melatonin probably reduces symptoms associated with jet lag
Is melatonin useful for jet lag? - Meta-analysis, 2006; 17 studies, 651 people; people with secondary sleep disorders and sleep restriction: no clear difference.
no evidence that melatonin had an effect on sleep onset latency
Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis - Systematic review, 2001; 10 studies; airline passengers, staff, military crossing time zones: improves.
decreased jet-lag from flights crossing five or more time zones
Melatonin for preventing and treating jet lag - Systematic review, 1997; patients with circadian rhythm sleep disorders: improves. [Melatonin--a natural hypnotic?]
- Systematic review, 1996; time zone travellers and night shift workers: improves. Use of melatonin in circadian rhythm disorders and following phase shifts
- Randomised trial, 2001; 27 people; US Air Force reservists: improves.
allows a faster resynchronization of hormone rhythms
Resynchronization of hormonal rhythms after an eastbound flight in humans: effects of slow-release caffeine and melatonin - Randomised trial, 1992; 30 people: improves.
self-ratings significantly discriminated between melatonin and placebo
Melatonin and jet lag: confirmatory result using a simplified protocol - Crossover trial, 1989; 20 people; twenty volunteers with transcontinental flight experience: improves.
Feelings of jet lag were less for subjects taking melatonin
Effect of melatonin on jet lag after long haul flights
- Systematic review, 2002; 10 studies; airline passengers, staff, or military personnel crossing time zones: improves (the review the verdict rests on).
Memory
The studies read do not show a clear benefit for memory. One reading found mixed results, a second reading of the same search found little or no difference. The evidence is very weak.
Possible harm: 2 studies read reported a worse result for memory with Melatonin. One abstract says: "Memory scanning speed and perception of mental load were adversely affected." Check the studies below, and ask a doctor or pharmacist if this applies to you.
8 studies counted of 11 read: 3 reviews and 5 trials (129 people in the trials).
- Systematic review, 2026: improves (the review the verdict rests on). Nutritional supplements and cognition in healthy aging and mild cognitive impairment patients: a systematic review and network meta-analysis
- Systematic review, 2025; 26 studies, 23,839 people; patients with cognitive dysfunction induced by multiple sclerosis: worsens. Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis
- Meta-analysis, 2021; 22 studies: no clear difference.
melatonin did not reduce memory function
Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer's disease and insomnia: A systematic review and meta-analysis of randomized controlled trials - Randomised trial, 2020; 36 people; women undergoing adjuvant chemotherapy for breast cancer: improves.
enhanced episodic memory (immediate and delayed) and recognition on RAVLT
Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial - Randomised trial, 2007; 13 people; non-sleep deprived volunteers: no clear difference. Cognitive performance following premature awakening from zolpidem or melatonin induced daytime sleep
- Crossover trial, 2007; healthy adults undergoing fMRI memory tasks: improves.
Exogenous melatonin further reduced activation in this region
Melatonin and the human hippocampus, a time dependent interplay - Crossover trial, 2005; 80 people; 80 healthy adults: no clear difference.
no memory or performance impairment (P > .05)
Daytime sleep and performance following a zolpidem and melatonin cocktail - Randomised trial, 1993; police officers working seven successive night shifts: worsens.
Memory scanning speed and perception of mental load were adversely affected
Can melatonin improve shift workers' tolerance of the night shift? Some preliminary findings
Sleep quality
The studies disagree. A Cochrane review (2018, 4 studies, 151 people) did not settle it for sleep quality, while 3 of the 8 studies read found an improvement. The evidence is very weak.
8 studies counted of 11 read: 7 reviews and 1 trial (57 people in the trials).
- Systematic review, 2018; 4 studies, 151 people; adults in the intensive care unit: unclear: evidence too weak to tell (the review the verdict rests on). Melatonin for the promotion of sleep in adults in the intensive care unit
- Systematic review, 2026; 98 studies, 28,920 people; individuals with chronic non-cancer pain: improves.
melatonin significantly improved sleep quality compared with placebo
Comparative effectiveness and safety of pharmacological interventions for sleep outcomes in chronic non-cancer pain: a systematic review and network meta-analysis - Meta-analysis, 2026; 23 studies, 2,028 people; people with chronic or postoperative musculoskeletal pain: mixed results.
Sleep quality favoured melatonin in people with chronic MSK pain
Efficacy and effectiveness of melatonin for the management of musculoskeletal pain: a systematic review and meta-analysis of placebo and active controlled trials - Systematic review, 2026; 23 studies, 1,941 people; adults with migraine and sleep disturbances: no clear difference. Interventions for Migraine and Sleep: A Systematic Review Exploring Their Bidirectional Association
- Systematic review, 2026; 7 studies, 497 people; menopausal women: no clear difference. A systematic review and meta-analysis of randomized controlled trials investigated the effects of melatonin supplementation on bone mineral density, quality of life, and sleep in menopausal women
- Meta-analysis, 2026; 4 studies, 455 people; patients undergoing total joint arthroplasty: no clear difference.
melatonin did not significantly impact subjective or objective sleep outcomes
Evaluating Whether Melatonin Impacts Postoperative Sleep Following Total Joint Arthroplasty: A Systematic Review and Meta-analysis of Randomized Controlled Trials - Meta-analysis, 2026; 7 studies, 409 people: improves. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis
- Randomised trial, 2026; 57 people; patients undergoing urological surgery: improves.
sleep-quality scores increased significantly in the melatonin group
The effect of preoperative melatonin patches on sleep quality in patients undergoing urological surgery
Stress
The best available review (2026, 10 studies) found an improvement in stress. That review studied patients with chronic kidney disease. 4 of the 5 studies read agree; 1 found mixed results. The evidence is moderate.
5 studies counted of 10 read: 4 reviews and 1 trial (49 people in the trials).
- Systematic review, 2026; 10 studies; patients with chronic kidney disease: improves (the review the verdict rests on). The effect of melatonin supplementation on lipid profile, oxidative stress, inflammatory marker, and sleep quality in patients with chronic kidney disease: a GRADE assessed meta-analysis
- Systematic review, 2024; 10 studies, 485 people: improves.
Melatonin increased superoxide dismutase in nine studies, glutathione peroxidase in seven studies, and catalase in …
Antioxidant Actions of Melatonin: A Systematic Review of Animal Studies - Meta-analysis, 2020; 12 studies: mixed results.
significant increase in total antioxidant capacity (TAC)
Effect of melatonin supplementation on oxidative stress parameters: A systematic review and meta-analysis - Meta-analysis, 2020; 15 studies: improves. Effects of melatonin supplementation on oxidative stress: a systematic review and meta-analysis of randomized controlled trials
- Randomised trial, 2026; 49 people: improves.
decrease in malondialdehyde, advanced oxidation protein products
Benefits of 12-week self-paced training combined with melatonin supplementation on oxidative stress, inflammation, hyperlipidemia, and body composition in multiple sclerosis patients: A randomized controlled trial
Key findings
- Insomnia Signs and SymptomsImproves (the measure goes down)
- Abdominal PainImproves (the measure goes down)
- Blood PressureImproves (the measure goes down)
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Third-party tested Melatonin products, in the forms the graded studies used where we can match them.
- Grade A
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
38 studies from PubMed
- Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin
- Effect of melatonin supplementation on body composition and blood pressure in adults: A systematic review and Dose-Response meta-analysis of randomized controlled trial.
- Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men
- Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men
- Melatonin administration and pituitary hormone secretion
- The effect of melatonin administration on pituitary hormone secretion in man
- Melatonin supplementation ameliorates oxidative stress and inflammatory signaling induced by strenuous exercise in adult human males
- The potential therapeutic effect of melatonin in Gastro-Esophageal Reflux Disease
- The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia
- Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia
- Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects
- Effect of melatonin on insomnia and daytime sleepiness, in patients with obstructive sleep apnea and insomnia (COMISA): A randomized double-blinded placebo-controlled trial.
- Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans
- Melatonin differentially affects vascular blood flow in humans
- Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome
- Influences of melatonin administration on the circulation of women
- Effects of Melatonin Supplementation On Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Treatment of central and sensorineural tinnitus with orally administered Melatonin and Sulodexide: personal experience from a randomized controlled study
- Melatonin: can it stop the ringing?
- The effects of melatonin on tinnitus and sleep
- Effect of melatonin on tinnitus
- Prophylaxis of migraine with melatonin: a randomized controlled trial
- Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention.
- Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
- Melatonin improves memory acquisition under stress independent of stress hormone release
- Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial
- A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers
- Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort
- Melatonin administrated immediately before an intense exercise reverses oxidative stress, improves immunological defenses and lipid metabolism in football players
- Melatonin for the prevention and treatment of jet lag
- Role of melatonin in mucosal gastroprotection against aspirin-induced gastric lesions in humans
- Effect of melatonin on intraocular pressure
- Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis
- The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials.
- Effects of melatonin supplementation on BDNF concentrations and depression: A systematic review and meta-analysis of randomized controlled trials.
- 12-week melatonin supplementation improved dynamic postural stability and walking performance in persons living with multiple sclerosis: A randomized controlled trial.
- 12-week melatonin intake attenuates cardiac autonomic dysfunction and oxidative stress in multiple sclerosis patients: a randomized controlled trial.
- The effect of melatonin supplementation on glycemic control in patients with type 2 diabetes.